Skip to content

CONTOUR NEXT GENRecalls & reported problems across all models

Ascensia Diabetes Care US Inc. · 5 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

1 open recall names at least one CONTOUR NEXT GEN model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
85
Deaths reported
0
Injuries reported
1
Recalls
1

We found 5 models of CONTOUR NEXT GEN by Ascensia Diabetes Care US Inc. in the FDA's device registry (GUDID). Together they are named in 85 adverse event reports in the FDA's MAUDE database, received between May 22, 2023 and Jan 7, 2026 — classified as 1 injury, 84 malfunctions.

The most frequently reported specific device problem is “Nonstandard Device” (50 reports).

1 FDA recall record name at least one of these models by its device identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 2 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 3 reportsApr 2024: 1 reportsMay 2024: 1 reportsJun 2024: 2 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 2 reportsOct 2024: 2 reportsNov 2024: 4 reportsDec 2024: 3 reportsJan 2025: 3 reportsFeb 2025: 1 reportsMar 2025: 4 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 2 reportsAug 2025: 1 reportsSep 2025: 2 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520264
Last 36 months. The most recent month may be incomplete.

CONTOUR NEXT GEN recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. May 19, 2023Open, Classified

    Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the meter kit and had incorrect factory-set unit of measure where the meters display glucose results in mmol/L rather than mg/dL. The standard unit of measurement for the United States is mg/dL. If a consumer does not notice the incorrect unit of measurement, it is possible that the meters glucose measurement will be read as a lower blood glucose measurement than expected, and this may result in the patients glucose level remaining high, which can potentially lead to an injury requiring immediate medical intervention.

    Z-2211-2023 · Root cause: Process control · Recall details · FDA record ↗

Most reported CONTOUR NEXT GEN problems

Device problems

  • Nonstandard Device50
  • Missing Test Results27
  • Incorrect, Inadequate or Imprecise Result or Readings4
  • Data Problem1
  • High Readings1
  • Low Readings1
  • Output Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions84
  • Insufficient Information1

CONTOUR NEXT GEN models

5 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent CONTOUR NEXT GEN adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Ascensia Diabetes Care US Inc. products

All Ascensia Diabetes Care US Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page